<?xml version="1.0" encoding="UTF-8"?>
<p>We have not discussed all aspects of vaccine trial design during epidemics of emerging infectious diseases. However, through a discussion of four fundamental choices and three ethical considerations, we hope to have highlighted the range of options that should be considered during future epidemics. A closely overlapping set of decisions has recently been incorporated into an online interactive decision tool as part of the WHO Research and Development Blueprint for Action to Prevent Epidemics (the InterVax-Tool: 
 <ext-link ext-link-type="uri" xlink:href="http://vaxeval.com/" xmlns:xlink="http://www.w3.org/1999/xlink">http://vaxeval.com/</ext-link>) [
 <xref rid="pmed.1002632.ref050" ref-type="bibr">50</xref>].
</p>
